Skip to main content

LifeMD Inc

For the period ended Mar 31, 2025. Filed May 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 6, 2025

LFMD$1.74-16.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Operations

Three Months Ended March 31,
20252024
Revenues
Telehealth revenue, net$52,456,481$30,841,402
WorkSimpli revenue, net13,241,27513,302,862
Total revenues, net65,697,75644,144,264
Cost of revenues
Cost of telehealth revenue8,136,4624,194,595
Cost of WorkSimpli revenue507,254405,582
Total cost of revenues8,643,7164,600,177
Gross profit57,054,04039,544,087
Expenses
Selling and marketing expenses29,194,06124,173,880
General and administrative expenses17,055,66915,305,732
Customer service expenses3,071,4941,848,041
Development costs2,675,1342,087,232
Other operating expenses2,514,7582,300,447
Total expenses54,511,11645,715,332
Operating income (loss)2,542,924(6,171,245)
Interest expense, net(626,275)(477,678)
Net income (loss)1,916,649(6,648,923)
Net income attributable to non-controlling interest531,845119,432
Net income (loss) attributable to LifeMD, Inc.1,384,804(6,768,355)
Preferred stock dividends(776,563)(776,563)
Net income (loss) attributable to LifeMD, Inc. common stockholders$608,241$(7,544,918)
Basic earnings (loss) per share attributable to LifeMD, Inc. common stockholders$0.01$(0.19)
Diluted earnings (loss) per share attributable to LifeMD, Inc. common stockholders$0.01$(0.19)
Weighted average number of common shares outstanding:
Basic43,135,77839,242,237
Diluted45,580,31139,242,237
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.